Publications

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

 85
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Next Article

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

Mislocalization of nucleic acids is a convergent and targetable mechanism in Alzheimer’s disease and frontotemporal dementia

Mislocalization of nucleic acids is a convergent and ta...

 82

Advances in menin inhibition in acute myeloid leukemia

Advances in menin inhibition in acute myeloid leukemia

 36

Repurposing glucose-lowering drugs for cancer therapy

Repurposing glucose-lowering drugs for cancer therapy

 131